Emanuele Rizzo

Dr. Emanuele Rizzo

Local Health Authority ASL Lecce, Lecce, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
EREmanuele Rizzo
Emanuele Rizzo

1 June 2021 in Environmental Research
Verified
Journal Article
Closed access
GMGiuseppe Maggiotto
Giuseppe Maggiotto
AMAlessandro Miani
Alessandro Miani
EREmanuele Rizzo
Emanuele Rizzo
MCMaria Domenica Castellone
Maria Domenica Castellone
PPPrisco Piscitelli
Prisco Piscitelli

13 February 2020 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
PPPrisco Piscitelli
Prisco Piscitelli
CNCosimo Neglia
Cosimo Neglia
MFMaurizio Feola
Maurizio Feola
EREmanuele Rizzo
Emanuele Rizzo
AAAlberto Argentiero
Alberto Argentiero
UTUmberto Tarantino
Umberto Tarantino

PPPrisco Piscitelli
Prisco Piscitelli
BVBarbara Valenzano
Barbara Valenzano
EREmanuele Rizzo
Emanuele Rizzo
GMGiuseppe Maggiotto
Giuseppe Maggiotto
MRMatteo Rivezzi
Matteo Rivezzi
Alessandro MianiAlessandro Miani
Alessandro Miani
Background: The Italian Society of Environmental Medicine has performed a preliminary assessment of the health impact attributable to road freight traffic in Italy. Methods: We estimated fine particulate matter (PM10, PM2.5) and nitrogen oxides (NOx) generated by road transportation of goods in Italy considering the number of trucks, the emission factors and the average annual distance covered in the year 2016. Simulations on data concerning Years of Life Lost (YLL) attributable to PM2.5 (593,700) and nitrogen oxides NO2 (200,700) provided by the European Environmental Agency (EEA) were used as a proxy of healthcare burden. We set three different healthcare burden scenarios, varying from 1/5 to 1/10 of the proportion of the overall particulate matter attributable to road freight traffic in Italy (about 7% on a total of 2262 tons/year). Results: Road freight traffic in Italy produced about 189 tons of PM10, 147 tons of PM2.5 and 4125 tons of NOx in year 2016, resulting in annual healthcare costs varying from 400 million up to 1.2 billion EUR per year. Conclusion: Road freight traffic has a relevant impact on air pollution and healthcare costs, especially if considered over a 10-year period. Any solution able to significantly reduce the road transportation of goods could decrease avoidable mortality due to air pollution and related costs.

20 September 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Luana ConteLuana Conte
Luana Conte
EREmanuele Rizzo
Emanuele Rizzo
ECEmanuela Civino
Emanuela Civino
PTPaolo Tarantino
Paolo Tarantino
Giorgio De NunzioGiorgio De Nunzio
Giorgio De Nunzio
EMELISABETTA DE MATTEIS
ELISABETTA DE MATTEIS
The association between genetics and lifestyle factors is crucial when determining breast cancer susceptibility, a leading cause of deaths globally. This research aimed to compare the body mass index, smoking behavior, hormonal influences, and BRCA gene mutations between affected patients and healthy individuals, all with a family history of cancer. All these factors were then utilized as features to train a machine learning (ML) model to predict the risk of breast cancer development. Between 2020 and 2023, a total of 1389 women provided detailed lifestyle and risk factor data during visits to a familial cancer center in Italy. Descriptive and inferential statistics were assessed to explore the differences between the groups. Among the various classifiers used, the ensemble of decision trees was the best performer, with a 10-fold cross-validation scheme for training after normalizing the features. The performance of the model was evaluated using the receiver operating characteristic (ROC) curve and its area under the curve (AUC), alongside the accuracy, sensitivity, specificity, precision, and F1 score. Analysis revealed that individuals in the tumor group exhibited a higher risk profile when compared to their healthy counterparts, particularly in terms of the lifestyle and genetic markers. The ML model demonstrated predictive power, with an AUC of 81%, 88% sensitivity, 57% specificity, 78% accuracy, 80% precision, and an F1 score of 0.84. These metrics significantly outperformed traditional statistical prediction models, including the BOADICEA and BCRAT, which showed an AUC below 0.65. This study demonstrated the efficacy of an ML approach in identifying women at higher risk of breast cancer, leveraging lifestyle and genetic factors, with an improved predictive performance over traditional methods.

3 March 2024 in Computation
Verified
Journal Article
Open access
PDF file
Luana ConteLuana Conte
Luana Conte
EREmanuele Rizzo
Emanuele Rizzo
TGTiziana Grassi
Tiziana Grassi
FBFrancesco Bagordo
Francesco Bagordo
EMELISABETTA DE MATTEIS
ELISABETTA DE MATTEIS
Giorgio De NunzioGiorgio De Nunzio
Giorgio De Nunzio
Pedigree charts remain essential in oncological genetic counseling for identifying individuals with an increased risk of developing hereditary tumors. However, this valuable data source often remains confined to paper files, going unused. We propose a computer-aided detection/diagnosis system, based on machine learning and deep learning techniques, capable of the following: (1) assisting genetic oncologists in digitizing paper-based pedigree charts, and in generating new digital ones, and (2) automatically predicting the genetic predisposition risk directly from these digital pedigree charts. To the best of our knowledge, there are no similar studies in the current literature, and consequently, no utilization of software based on artificial intelligence on pedigree charts has been made public yet. By incorporating medical images and other data from omics sciences, there is also a fertile ground for training additional artificial intelligence systems, broadening the software predictive capabilities. We plan to bridge the gap between scientific advancements and practical implementation by modernizing and enhancing existing oncological genetic counseling services. This would mark the pioneering development of an AI-based application designed to enhance various aspects of genetic counseling, leading to improved patient care and advancements in the field of oncogenetics.